Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis

Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis

(2015) Yoshihito Ogawa et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

Drotrecogin Alfa (Activated) in Adults with Septic Shock

(2012) V. Marco Ranieri et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnosis and treatment of disseminated intravascular coagulation: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)

(2011) Marcello Di Nisio et al.   THROMBOSIS RESEARCH

Inflammation and coagulation

(2010) Marcel Levi et al.   CRITICAL CARE MEDICINE

Propensity scores in intensive care and anaesthesiology literature: a systematic review

(2010) Etienne Gayat et al.   INTENSIVE CARE MEDICINE

THROMBOMODULIN ALFA IN THE TREATMENT OF INFECTIOUS PATIENTS COMPLICATED BY DISSEMINATED INTRAVASCULAR COAGULATION

(2010) Naoki Aikawa et al.   SHOCK

Guidelines for the diagnosis and management of disseminated intravascular coagulation

(2009) M Levi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: Results of a multicenter, prospective survey*

(2009) Satoshi Gando et al.   CRITICAL CARE MEDICINE

Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia

(2009) Masaru Nagato et al.   CRITICAL CARE MEDICINE

Expert consensus for the treatment of disseminated intravascular coagulation in Japan

(2009) Hideo Wada et al.   THROMBOSIS RESEARCH

The coagulation system and pulmonary endothelial function in acute lung injury

(2008) James H. Finigan   MICROVASCULAR RESEARCH